[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100634118":3},{"organization":4,"armGroups":7,"interventions":26,"overallOfficials":33,"centralContacts":37,"locations":43,"responsibleParty":60,"collaborators":32,"id":63,"slug":32,"hasResults":64,"nctId":65,"briefTitle":66,"officialTitle":67,"acronym":32,"eligibilityCriteria":68,"healthyVolunteers":69,"sex":70,"minAge":71,"maxAge":32,"enrollmentInfo":72,"targetDuration":32,"studyType":75,"phases":76,"briefSummary":78,"conditions":79,"keywords":83,"overallStatus":88,"whyStopped":32,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"University of Valencia","OTHER",[8,14,18,22],{"label":9,"type":10,"description":11,"interventionNames":12},"-2 mm subcrestal implant placement with 2-mm slim transmucosal abutments","EXPERIMENTAL","Participants in this group will receive implants placed 2 mm below the level of the alveolar bone crest. Implants will share the same design, surface characteristics, and prosthetic connection, including platform switching. Slim transmucosal abutments with a height of 2-mm will be placed according to the subcrestal depth to ensure an adequate transmucosal profile and a stable relationship between the implant, peri-implant soft tissues, and the prosthetic restoration",[13],"Procedure: Subcrestal Implant Placement with Transmucosal Abutment and One Abutment-One Time Protocol",{"label":15,"type":10,"description":16,"interventionNames":17},"-2 mm subcrestal implant placement with 3-mm slim transmucosal abutments","Participants in this group will receive implants placed 2 mm below the level of the alveolar bone crest. Implants will share the same design, surface characteristics, and prosthetic connection, including platform switching. Slim transmucosal abutments with a height of 3-mm will be placed according to the subcrestal depth to ensure an adequate transmucosal profile and a stable relationship between the implant, peri-implant soft tissues, and the prosthetic restoration.",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"-4 mm subcrestal implant placement with 4-mm slim transmucosal abutments","Participants in this group will receive implants placed 4 mm below the level of the alveolar bone crest. Implants will share the same design, surface characteristics, and prosthetic connection, including platform switching. Slim transmucosal abutments with a height of 4-mm will be placed according to the subcrestal depth to ensure an adequate transmucosal profile and a stable relationship between the implant, peri-implant soft tissues, and the prosthetic restoration.",[13],{"label":23,"type":10,"description":24,"interventionNames":25},"-4 mm subcrestal implant placement with 5-mm slim transmucosal abutments","Participants in this group will receive implants placed 4 mm below the level of the alveolar bone crest. Implants will share the same design, surface characteristics, and prosthetic connection, including platform switching. Slim transmucosal abutments with a height of 5-mm will be placed according to the subcrestal depth to ensure an adequate transmucosal profile and a stable relationship between the implant, peri-implant soft tissues, and the prosthetic restoration.",[13],[27],{"type":28,"name":29,"description":30,"armGroupLabels":31,"otherNames":32},"PROCEDURE","Subcrestal Implant Placement with Transmucosal Abutment and One Abutment-One Time Protocol","Participants will receive bone-level dental implants placed subcrestally at either -2 mm or -4 mm below the bone crest in healed posterior sites of the maxilla or mandible, according to randomization. Implant placement will follow the manufacturer's drilling protocol, achieving a final insertion torque of at least 35 Ncm. A transmucosal abutment will be connected at the time of surgery, with height selected based on implant placement depth (2-3 mm for -2 mm placement and 4-5 mm for -4 mm placement). The abutment will be tightened to a final torque of at least 30 Ncm following a one abutment-one time protocol.",[9,15,19,23],null,[34],{"name":35,"affiliation":5,"role":36},"Ana Verónica Blanco Besteiro, DDS, MSc and PhD candidate","PRINCIPAL_INVESTIGATOR",[38],{"name":39,"role":40,"phone":41,"phoneExt":32,"email":42},"Juan Carlos Bernabeu Mira, DDS, MSc, PhD","CONTACT","+34 697348312","juan.c.bernabeu@uv.es",[44],{"facility":5,"status":32,"city":45,"state":45,"zip":46,"country":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"Valencia","46003","Spain",{"type":49,"coordinates":50},"Point",[51,52],-0.37966,39.47391,{"lat":52,"lon":51},[55,56],{"name":39,"role":40,"phone":41,"phoneExt":32,"email":42},{"name":57,"role":40,"phone":58,"phoneExt":32,"email":59},"David Peñarroha Oltra, DDS, MSc, PhD","+34 649952560","david.penarrocha@uv.es",{"type":36,"investigatorFullName":61,"investigatorTitle":62,"investigatorAffiliation":5,"oldNameTitle":32,"oldOrganization":32},"Juan Carlos Bernabeu Mira","Professor, PhD","100634118",false,"NCT07535528","Implant Placement Depth and Peri-Implant Tissue Outcomes","Influence of Implant Placement Depth (-2 mm vs -4 mm Subcrestal) on Peri-implant Tissue Conditions: a Randomized Clinical Trial Protocol","Inclusion Criteria:\n\n* Patients ≥18 years old with partial edentulism.\n* Need for rehabilitation with fixed implant-supported prostheses in posterior regions.\n* Availability of minimum bone height for implants ≥6 mm in length.\n* Minimum bone width without the need for guided bone regeneration.\n* Supracrestal soft tissue thickness ≥2 mm.\n* Non-smokers or smokers of ≤10 cigarettes\u002Fday.\n* Plaque index and bleeding on probing \\\u003C20%.\n* Probing depth ≤3 mm.\n* Signed informed consent.\n\nExclusion Criteria:\n\n* Systemic diseases contraindicating implant surgery.\n* Treatment with intravenous bisphosphonates.\n* Head and neck radiotherapy.\n* Uncontrolled diabetes.\n* Pregnancy or breastfeeding.\n* Alcohol or drug use.\n* Psychiatric disorders.\n* Need for bone regeneration procedures.\n* Inability to complete follow-up.\n* Implant failure during the study period.",true,"ALL","18 Years",{"count":73,"type":74},80,"ESTIMATED","INTERVENTIONAL",[77],"NA","The primary aim of this randomized clinical trial is to evaluate the influence of subcrestal implant placement depth (-2 mm vs -4 mm) on peri-implant marginal bone level changes, including marginal bone loss and bone remodeling. Secondary outcomes include implant success, peri-implant probing depth (PPD), and bleeding on probing (BoP).\n\nPartially edentulous patients requiring fixed implant-supported prosthetic rehabilitation with two implants in posterior maxillary or mandibular regions will be included. Implants will be placed subcrestally at either -2 mm or -4 mm from the bone crest, following a submerged healing protocol. Allocation to insertion depth will be randomized. Marginal bone level changes will be assessed using standardized periapical radiographs at second-stage surgery, prosthesis placement, and at 1, 3, 6, and 12 months after functional loading. PPD and BoP will be recorded at the same time points.",[80,81,82],"Dental Implant Placement","Soft Tissue Management in Subcrestal Dental Implants","Marginal Bone Loss",[84,85,86,87],"Dental implant","Subcrestal placement","Marginal bone loss","Insertion depth","NOT_YET_RECRUITING","2026-04-14",{"date":91,"type":92},"2026-04-17","ACTUAL",{"date":94,"type":74},"2026-05-15",{"date":96,"type":74},"2027-07-20",{"name":5,"class":6},1]